Business
Time to debunk anti-vaxxer myths: CSL CEO – The Australian Financial Review
Demand for CSL’s core plasma products and surging government orders for flu vaccines has resulted in the biotech giant lifting the bottom end of its 2021 profit…
“We don’t have the ability to just turn on a dime and start making more flu vaccines … when we start the manufacturing process it’s pretty well done… and to turn and make more is very difficult late in the season, but we’ve had good yield
Continue Reading
-
Noosa News17 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News18 hours agoMotorcyclist dies in crash with truck
-
Noosa News19 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General24 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging